Azelastine and Osteomyelitis - a phase IV clinical study of FDA data

Summary:

Osteomyelitis is reported as a side effect among people who take Azelastine (azelastine hydrochloride), especially for people who are female, 60+ old, also take Prednisone, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Osteomyelitis when taking Azelastine. It is created by eHealthMe based on reports of 17,147 people who have side effects when taking Azelastine from the FDA, and is updated regularly.

What is Azelastine?

Azelastine has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 17,398 Azelastine users. Check the latest studies of Azelastine.

What is Osteomyelitis?

Osteomyelitis (infection of bone) is found to be associated with 1,438 drugs and 1,318 conditions by eHealthMe. Check the latest studies of Osteomyelitis.

On Apr, 18, 2026

17,147 people reported to have side effects when taking Azelastine.
Among them, 42 people (0.24%) have Osteomyelitis.

Among these 42 people:

What is the gender of people who have Osteomyelitis when taking Azelastine? *

female: 59.52 %
male: 40.48 %

What is the age of people who have Osteomyelitis when taking Azelastine? *

What are other drugs people take besides Azelastine? *

What are other side effects people have besides Osteomyelitis? *

Pain: 26 people, 61.90%
Insomnia (sleeplessness): 21 people, 50.00%
Cough: 19 people, 45.24%
Hypoaesthesia (reduced sense of touch or sensation): 18 people, 42.86%
Fatigue (feeling of tiredness): 18 people, 42.86%
Chest Pain: 18 people, 42.86%
Dyspnea (difficult or laboured breathing): 18 people, 42.86%
Rashes (redness): 18 people, 42.86%
Productive Cough: 16 people, 38.10%
Diarrhea: 16 people, 38.10%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 16 people, 38.10%
Dehydration (dryness resulting from the removal of water): 6 people, 14.29%
Sleep Disorder: 5 people, 11.90%
Sleep Apnea Syndrome: 5 people, 11.90%
Asthma: 4 people, 9.52%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 9.52%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 4 people, 9.52%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.52%
Hypersensitivity: 4 people, 9.52%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Azelastine and have Osteomyelitis?

- Check whether Osteomyelitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azelastine:

Azelastine (17,398 reports)

Osteomyelitis treatments and more:

Osteomyelitis (34,172 reports)

Browse all side effects of Azelastine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteomyelitis:

Osteomyelitis (1,438 drugs)

Browse all the conditions that are associated with Osteomyelitis:

Osteomyelitis (1,318 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azelastine hydrochloride (the active ingredients of Azelastine) and Azelastine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.